PrEP May Cause a Revolution in HIV Prevention: Time to Get Ready

Similar documents
Pre-Exposure Prophylaxis (PrEP) A Biomedical Intervention Prevention with Negatives Antiretroviral Prevention

On the Horizon for Consideration: Biomedical Advances in HIV Prevention

Inspiring HIV Prevention Innovations for Women. IPM Satellite Event Durban, 13 th June 2017 Annalene Nel

Update on ARV based PrEP

WOMEN & HIV: A GLOBAL UPDATE. Deanna Kerrigan, PhD, MPH Associate Professor Health, Behavior & Society

Multiple choice questions: ANSWERS

Colloque scientifique : L économie de la prévention Analysis of Cost-Effectiveness of HIV Prevention

Biomedical Prevention in HIV

Strategic use of antiretroviral drugs to prevent HIV transmission

Antiretroviral Drugs for HIV Seronegative People: It works in trials, what about the real world?

M2010 Pre-Conference Workshop, Pittsburgh 22 May 2010

Biomedical HIV Prevention & PrEP Pre exposure Prophylaxis 2013

Pre-exposure prophylaxis : Systemic and topical. Linda-Gail Bekker The Desmond Tutu HIV Centre UCT SA HIV ClniciansSociety Conference 2012

Using anti-hiv drugs for prevention

HIV Prevention Strategies HIV Pre-exposure prophylaxis

ART and Prevention: What do we know?

Pre-Exposure Topical Microbicides and Oral Prophylaxis Trials:

Biomedical Prevention Update Thomas C. Quinn, M.D.

Combination HIV Prevention

ARVs for prevention in at-risk populations: Microbicides

ETHICS IN HIV PREVENTION RESEARCH IN THE NEW ERA OF

PrEP: Pre Exposure Prophylaxis

Program to control HIV/AIDS

Review of planned trials and key emerging issues for Thailand

HIV: Pregnancy in Serodiscordant Couple. Dr Chow TS ID Clinic HPP

The Big Picture: The current and evolving HIV prevention landscape

Combination HIV Prevention Research Carl W. Dieffenbach, Ph.D.

Understanding the Results of VOICE

Disclosure. Learning Objectives. Epidemiology. Transmission. Risk of Transmission PRE-EXPOSURE PROPHYLAXIS (PREP) FOR HIV PREVENTION 50,000.

PEP and PrEP: AWAAC 2014

Combination prevention: Public health and human rights imperatives

ART for HIV Prevention:

Government of Canada Federal AIDS Initiative Milestones

HIV Prevention in Clinical Care Settings

The Big Picture: The current and evolving HIV prevention landscape

Towards universal access

ACCELERATING HIV COMBINATION PREVENTION HIV COMBINATION PREVENTION INTERVENTIONS

Renewing Momentum in the fight against HIV/AIDS

CAN MONEY REDUCE HIV RISK?? Audrey Pettifor, PhD MPH Department of Epidemiology, University of North Carolina

HIV Prevention. Recent Advances and Implications for the Caribbean

Roy M. Gulick, MD, MPH Chief, Division of Infectious Diseases Professor of Medicine Weill Medical College of Cornell University New York City

HIV Prevention Prioritization & Implementation Brief: Gombe State

HIV In South Africa: Turning the Tide of the Epidemic

Antiretrovirals for HIV prevention:

Building Long-term Capacity for HIV/AIDS in Africa: S-S and Regional Strategies

Where are we going after effectiveness studies?

Biomedical HIV Prevention & TaP Treatment as Prevention 2013

International Partnership for Microbicides

HIV Prevention Prioritization & Implementation Brief: Kaduna State

HIV PREP THE NEWEST TOOL IN THE BOX

Sexual and Reproductive Health and HIV. Dr. Rita Kabra Training course in Sexual and Reproductive Health Research Geneva 2012

Recent Breakthroughs in HIV Prevention for Men who Have Sex with Men and Transgender Populations

HIV Prevention: 2010

Professor Thomas Quinn Johns Hopkins Center for Global Health, Maryland, USA

Getting to zero HIV new infections in Asia and the Pacific region: Possible or impossible dream?

Thresia Sebastian MD, MPH University of Colorado, Denver Global Health Disasters Course October 2016

Treat All : From Policy to Action - What will it take?

Modernization of North Carolina s HIV control measures

PEP and PREP. Dr David Hawkins Chelsea and Westminster Hospital

Is this the end of AIDS? New advances in HIV prevention. James McIntyre Anova Health Institute and University of Cape Town School of Public Health

Update on PrEP progress: WHO/UNAIDS challenges and actions

Novel HIV Prevention Methods for Women

Fertility Desires/Management of Serodiscordant HIV + Couples

Can we treat our way out of the HIV epidemic?

HIV: A global perspective on epidemiology, diagnosis and prevention

QUESTIONS AND ANSWERS ABOUT PARTNERS PrEP AND VOICE

Where We Have Been and Where We are Going. Ian McGowan MD PhD FRCP

Page 1. Outline. Outline. Building specialized knowledge: HIV. Biological interactions. Social aspects of the epidemic. Programmatic actions

HIV in Zambia MINISTRY OF HEALTH. Dr Albert Mwango, BScHB, MBChB, MPH National Antiretroviral Program Coordinator,

Supplementary Material Table 5. Ongoing PrEP studies among young key population, young people, and key populations. Age range. Study name and location

Evolving HIV Treatment Paradigms What we need to know

HIV Prevention Prioritization & Implementation Brief: Anambra State

HIV / AIDS. Prevention In Our Lives

Overview of ARV-based prevention trials

Update on Biomedical Prevention. Thomas C. Quinn, MD, MSc

HIV Prevention Prioritization & Implementation Brief: Benue State

HIV/AIDS and Drug Use in the United States: A Domestic Agenda

OR: Steps you can take in the clinic to prevent HIV infections

HIV Vaccine Clinical Trials at CIDRZ

To provide you with the basic concepts of HIV prevention using HIV rapid tests combined with counselling.

PrEP 201: Beyond the Basics

Welcome to the National Association of County and City Health Officials Webinar on PrEP and Local Health Departments

Learning from the past: How prepared are we for future HIV vaccine efficacy trials in Uganda

Aligning UNICEF s HIV Vision to the SDGs and UNAIDS Strategy. Dr. Chewe Luo Chief, HIV/AIDS Section UNICEF NYHQ 5 April 2016

HIV Treatment as Prevention (TasP)

What s in the Biomedical Prevention Pipeline

ISSUE BRIEF. Accelerating an HIV Prevention Revolution: A Roadmap

HIV TRANSMISSION AND PREVENTION KENNETH H. MAYER, M.D. BROWN UNIVERSITY/MIRIAM HOSPITAL FENWAY COMMUNITY HEALTH 5/31/07

Pre-exposure Prophylaxis (PrEP)

Doing studies of ARV based

The Beginning of the End of AIDS Diane V. Havlir, MD

United Nations General Assembly June 8, 2011

UNGASS Declaration of Commitment on HIV/AIDS: Core Indicators revision

HIV und AIDS- was gibt es Neues für die Arbeit vor Ort?

PrEP Home Checklist v1.0

Reflections on the use of future HIV vaccines as part of an integrated package of preventive measures

HIV Prevention among Women

11/8/2016. The Challenge of HIV Treatment

PREVENTION OF HIV-1 Infection. Myron S. Cohen, MD Institute for Global Health The University of North Carolina

PrEP for Women. Together, we can change the course of the HIV epidemic one woman at a time.

Transcription:

PrEP May Cause a Revolution in HIV Prevention: Time to Get Ready Thomas J. Coates PhD Michael and Sue Steinberg Professor of Global AIDS Research David Geffen School of Medicine University of California, Los Angeles, USA

A New Team of Two in Charge of HIV Prevention Photo Courtesy of Bernie Branson - CDC

ART ART to to Reduce VL VL and and protect Partners HPTN HPTN 052 052 Effective IDU IDU Treatment w/ w/ Bupren/Nalox HPTN HPTN 058 058 MSM: MSM: Reduce Reduce Risks Risks for for A-A A-Aand and for for Stimulant- Users Users In In progress Highly Active HIV Prevention Reduce Risk Risk for for Vulnerable Women In In progress Adolescent Risk Risk Reduction PrEP PrEP and and Behavior HPTN HPTN 060 060 Improve education and and access to to care care for for all all HPTN HPTN 043 043 Restore mucosal Integrity MSM MSM && Women HPTN HPTN 039 039

The 9 Best Things in HIV Prevention 1. Demonstrations that HIV prevention is possible and requires radical, not subtle, behavioral change

Progress is Possible! Not simple Not subtle Not simplistic and usually multisectoral No magic bullet But change has happened We have an idea of what made it happe

The 10 Best Things in HIV Prevention 1. Demonstrations that HIV prevention is possible and requires radical, not subtle, behavioral change 2. Knowledge of what does not work 3. The male and female condom 4. Other behavioral options delay, reduction in partner number 5. The HIV test given to individuals, couples, families, communities 6. Prevention of mother-to-child transmission using anti-hiv treatment 7. Access to clean needles and syringes for drug users; drug treatment; substitution therapy for drug use 8. Male circumcision 9. Treatment for HIV (we think) 10. Pre-exposure prophylaxis (we hope) v

The 3 Worst Things in HIV Prevention 1. Unparalleled impediments 2. Driven by ideology 3. Lack of preparation for innovation

Clinical Trials of Biomedical Prevention Strategies: 2006 and Beyond Male Circumcision Susceptibility Vaccine Merck Adeno x2 STEP/Phambili Female Barrier Diaphragm Microbicides Carraguard Microbicides CS-1 CS-2 HSV-2 Treatment Infectiousness Oral PrEP MSM USA Safety Vaccine Thai Prime/Boost Community VCT and HIV Support Oral PrEP IDU/Thai Microbicides TDF/PMPA (CAPRISA) Oral PrEP MSM (iprex) Vaccine HVTN 505 Vaccine VRC PAVE 100 Oral PrEP Heterosexual (FemPrEP) Oral PrEP Serodisc (Partners) Vaginal & Oral PrEP (VOICE) Oral PrEP West Africa Male Circumcision Infectiousness HSV-2 Treatment Susceptibility Microbicides BG/Pro2000 Pro2000 Oral PrEP Heterosexual (Botswana) Index Partner Treatment (HPTN 052) 2006 2007 2008 2009 2010 2011++ See also http://www.avac.org/timeline-website/index.htm

Getting Ready for the Revolution Issue #1: Context and Messaging

Holistic Approach to Prevention Scheer et al, STI, 2009

Interventions to Prevent HIV Counseling and Testing for HIV HIV+ Newly HIV+ HIV- exposing others infectiousness exposure susceptibility

ART to Prevent Sexual Transmission of HIV Pre-exposure Prophylaxis (PREP) -oral -topical -parenteral Post-exposure prophylaxis (npep) USPH Guidelines 2003 Treatment of the infected person (index case) -observational results -HPTN 052/ACTG5245

Craigslist Serosorting I'm 26, 6' 165 white guy who wants a guy to fuck me raw tonight. I'm neg/std free and you should be too. Get back to me if interested.. Provided by Courtesy of Craigslist

Getting Ready for the Revolution Context and Messaging

Focus, Clarity of Goals, Precise Outcomes, Clear Management CT for HIV PrEP PMTCT M Circ Tx for HIV CT for HIV CT for HIV

Implications of the New Framework Range of Behaviors Is of Interest Testing and retesting Care-seeking And barriers to care Adherence to medications Actions to avoid spreading HIV Disclosure

Getting Ready for the Revolution Issue #3: Will HIV Prevention Be An Indication for Use?

Getting Ready for the Revolution Issue #4: Getting PrEP to the Right People

Get the Simple Things Right

What About the Domestic Epidemic?

HIV Incidence by Frequency of Stimulant Use, EXPLORE Overall Seroincidence 2.1/100 p-yrs Frequency of use HIV incidence % of cohort % of infections None 1.6 75% 56% Less than weekly 3.4 20% 32% Weekly or more 6.4 5% 12%

What About the Domestic Epidemic? Source: http://www.cdc.gov/hiv/topics/surveillance/resources/factsheets/prevalence.htm

HPTN 061: Feasibility Study of a Community-Based, Multi-component HIV Prevention Intervention for Black MSM (in preparation for a community-randomized efficacy trial) KENNETH H. MAYER M.D. and BERYL KOBLIN PhD SWG Presentation May 19,2008

HIV infections : the World, Africa & South Africa Population HIV Infections 6.5 billion 33.2 million 2.5 million new infections per year 896.7 million 13.74% 22.5 million 68% 46.8 million 0.72% 5.7 million 17% >100,000 new infections per year UNAIDS 2007 data

4 m people receiving ART by end of 2008 6.7m people need treatment and are in danger of losing their lives 2.7m became infected in 2007 Only 1m placed on ART in 2007

Getting Ready for the Revolution Issue #5: Side effects and disinhibition

Getting Ready for the Revolution Issue #6: We Need to Plan the Followon Studies Now

Getting Ready for the Revolution Issue #7: Getting the Advantages of Medicalization of Prevention but Leaving the Baggage Behind

Getting Ready for the Revolution Issue #8: ASOs and Financing